--- title: "PERTH 2: Co-design of a Home-based Monitoring Service for Cancer Patients to Optimize Delivery of Systemic Therapy." nct_id: NCT03923296 overall_status: COMPLETED sponsor: Entia Ltd study_type: OBSERVATIONAL primary_condition: Cancer countries: United Kingdom canonical_url: "https://parkinsonspathways.com/agent/trials/NCT03923296.md" clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT03923296" ct_last_update_post_date: 2022-04-06 last_seen_at: "2026-05-12T07:00:14.185Z" source: ClinicalTrials.gov (mirrored, no enrichment) --- # PERTH 2: Co-design of a Home-based Monitoring Service for Cancer Patients to Optimize Delivery of Systemic Therapy. **Official Title:** PERTH 2: Co-design of a Home-based Monitoring Service for Cancer Patients, Carers and Health Care Professionals to Optimize Delivery of Systemic Therapy. **NCT ID:** [NCT03923296](https://clinicaltrials.gov/study/NCT03923296) ## Key Facts - **Status:** COMPLETED - **Study Type:** OBSERVATIONAL - **Target Enrollment:** 62 - **Lead Sponsor:** Entia Ltd - **Conditions:** Cancer - **Start Date:** 2019-05-20 - **Completion Date:** 2021-07-16 - **CT.gov Last Update:** 2022-04-06 ## Brief Summary Iterative co-design study where patients receiving systemic cancer therapy, carers and healthcare professionals involved in delivering cancer therapy, work with Entia to design a home based blood monitoring service. The iterative process means that at each stage of the development process, Entia will be building on what is learnt in the previous stage. ## Detailed Description The study will use feedback provided by patients, carers and heatlhcare professionals to inform the changes that are necessary to develop a successful, user friendly home-based blood monitoring service for cancer patients. ## Eligibility - **Minimum age:** 16 Years - **Sex:** ALL - **Healthy Volunteers:** No ``` Inclusion Criteria: * Adequate english to participate in focus groups and workshops without an interpreter * Patients of the study site who are currently undergoing systemic therapy or have previously undergone systemic therapy within the past 12 months * Patients willing to participate in at least 60-minute and ideally 90-minute workshops at the designated study location, time and date. * Patients capable of providing informed consent before attending the first workshop For carers * Should be the primary carer nominated by a patient who fulfils the inclusion criteria, this includes parents of affected children * Should be willing to participate in at least a 60-minute and ideally 90-minute workshops at the designated study location, time and date. * Carers can only participate in the study with the cancer patient he/she is caring for. The patient has to also involved in the study * Carers need to be capable of providing informed consent before attending the first workshop For healthcare professionals * All clinicians need to be current employees of the study site * Doctors need to be employed at Specialist Registrar, Fellow or Consultant Level * Nurses of all grades are invited to participate but ideally need to have had some involvement in the outpatient care of oncology patients All participants:- * Should be willing to have the session's recorded audio, transcripts and analysed data from the focus groups/workshops shared with Entia Ltd. * should be willing to attend multiple 60 to 90 minute workshops. * should be willing for photos and video footage to be taken during the interview. * Participants attending workshops later in the development process must be comfortable consenting to finger prick testing/ assessing the ease of use of the test disposable Exclusion Criteria: For patients * Does not have adequate English to participate in focus group interview without an interpreter * Patients of the study site who are not currently undergoing systemic therapy or have previously undergone systemic therapy within the past 12 months * Patients not willing to participate in at least 60-minute and ideally 90-minute focus group discussion at the designated study location, time and date. * Participant not capable of providing consent or have a suitable, legally acceptable representative present to provide consent before the focus group interview. For carers * Is not the nominated primary carer of a cancer patient who fulfils the inclusion criteria, this includes parents of affected children * Not paired with a patient that is involved in the study * Carers not willing to participate in at least a 60-minute and ideally 90-minute focus group discussion at the designated study location, time and date. For healthcare professionals ● Doctors who are not employed at Specialist Registrar, Fellow or Consultant Level ``` ## Arms - **HCPs** — Health care professional interviews (market research) - **Patients or caregivers** — Patients or caregivers interviews ## Interventions - **Blood measurement and monitoring** (DEVICE) — Blood from a single fingerprick will be used to used to measure and monitor patients blood parameters. - **Interviews** (BEHAVIORAL) — Focus group interviews ## Primary Outcomes - **Qualitative capture of user feedback- focus groups** _(time frame: 30 months)_ — Participant feedback on the iterative designs of a future home-based monitoring service in order to arrive at a final prototype device and service design, suitable for patient, carer and healthcare professional's use. ## Locations (1) - The Christie NHS Foundation Trust, Manchester, United Kingdom ## Recent Field Changes (last 30 days) - `status.overallStatus` — added _(2026-05-12)_ - `status.primaryCompletionDate` — added _(2026-05-12)_ - `status.completionDate` — added _(2026-05-12)_ - `status.lastUpdatePostDate` — added _(2026-05-12)_ - `design.enrollmentCount` — added _(2026-05-12)_ - `eligibility.criteria` — added _(2026-05-12)_ - `eligibility.minAge` — added _(2026-05-12)_ - `eligibility.sex` — added _(2026-05-12)_ - `outcomes.primary` — added _(2026-05-12)_ - `armsInterventions.arms` — added _(2026-05-12)_ - `armsInterventions.interventions` — added _(2026-05-12)_ - `sponsor.lead` — added _(2026-05-12)_ - `results.hasResults` — added _(2026-05-12)_ - `locations.the christie nhs foundation trust|manchester||united kingdom` — added _(2026-05-12)_ --- *Canonical: https://parkinsonspathways.com/agent/trials/NCT03923296.md* *Source data (authoritative): https://clinicaltrials.gov/study/NCT03923296* *This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*